Special Interest

Malignant Hyperthermia From 1900 to Present Day (.75 Class A CE with .5 Pharm)

Sunday, September 23
11:45 AM - 12:30 PM
Location: Room 312, Hynes

Ryanodex is a new corner to the treatment of Malignant Hyperthermia. Is it better or worse than dantrolene? Why should you have it in your facility and what happens when you don't? How to prepare for a Malignant Hyperthermia patient.

Learning Objectives:

Heather Frankenfield, MSN, CRNA

Pediatric CRNA Educator
Vanderbilt University Medical Center
Nashville, Tennessee

I have been a registered nurse since 2003. My entire nursing career has been at Vanderbilt University Medical Center (VUMC). I started as a trauma bedside nurse, and advanced through being a charge nurse to the trauma assistant manager. I decided to go back to CRNA School in November of 2006.During CRNA School I found that my calling was to be a pediatric nurse anesthetist. The joy that pediatric patients brought to my life was immeasurable. In January of 2010, I was hired by Vanderbilt University Medical Center to work as a Nurse Anesthetist at MCJCHV. I have since loved coming to work daily,value my colleagues and profession. In April of 2014, I took the pediatric CRNA educator role, and now continuously work to improve our education endeavors throughout our department. In 2016 I did perioperative education regarding malignant hyperthermai that spread throughout our pediatric hosptial and to all the advanced practice nurses at VUMC. Helped in coordinating simulation training for MH crisis.

Presentation(s):

Send Email for Heather Frankenfield


Assets

Malignant Hyperthermia From 1900 to Present Day (.75 Class A CE with .5 Pharm)

Slides

Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Malignant Hyperthermia From 1900 to Present Day (.75 Class A CE with .5 Pharm)